Diet and Depression
A growing body of evidence suggests that a diet that promotes heart health also supports brain health.
Benzodiazepines and Dementia
Benzodiazepines probably do not contribute to the risk of irreversible cognitive decline, but they should be used sparingly and cautiously in older patients.
Antidepressants, Heart Disease, and Mortality
Depression can present life-threatening risks to patients with heart conditions, but antidepressant medications can be both protective and potentially hazardous in this population.
A High and Increasing Trajectory of Depressive Symptoms Is Associated with Increased Risk of Dementia; Androgen Deprivation Therapy for Prostate Cancer is Linked to Depression
Antidepressant Adherence Lowers Mortality Risk
Poor antidepressant adherence can lead to a greater risk of relapse, recurrence, and chronic symptoms, and new evidence suggests it also increases the risk of all-cause mortality.
Continuing Medical Education credits available!
Now provided by The CME Institute of Physicians Postgraduate Press, Inc. After reading this volume of Biological Therapies in Psychiatry (BTP), the learner will be able to (1) discuss new psychiatric drugs, including side effects and drug interactions, and (2) describe new information on older medications and new biological treatments.
The CME Institute of Physicians Postgraduate Press, Inc., is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The CME Institute of Physicians Postgraduate Press, Inc., designates this enduring material for a maximum of 12 AMA PRA Category 1 Credits.™ Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The CME posttest will be provided with the December 2016 issue of BTP. To obtain credit, you must answer 18 of 24 questions correctly and return the answer sheet to the CME Institute of Physicians Postgraduate Press, Inc., by March 31, 2017. The cost for this activity is $30.